Blue Water Vaccines Statistics Share Statistics Blue Water Vaccines has 18.9M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 18.9M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 13.9M Failed to Deliver (FTD) Shares 2,827 FTD / Avg. Volume 0.65%
Short Selling Information Short Interest n/a Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) n/a
Valuation Ratios The PE ratio is -1.02 and the forward
PE ratio is null.
Blue Water Vaccines's PEG ratio is
0.
PE Ratio -1.02 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.6 P/FCF Ratio -1.55 PEG Ratio 0
Financial Ratio History Enterprise Valuation Blue Water Vaccines has an Enterprise Value (EV) of -12.25M.
EV / Sales 0 EV / EBITDA 0.91 EV / EBIT 1.41 EV / FCF 1.41
Financial Position The company has a current ratio of 6.69,
with a Debt / Equity ratio of 0.
Current Ratio 6.69 Quick Ratio 6.69 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 219.53
Financial Efficiency Return on Equity is -59.36% and Return on Invested Capital is -59.63%.
Return on Equity -59.36% Return on Assets -50.51% Return on Invested Capital -59.63% Revenue Per Employee n/a Profits Per Employee $-1.11M Employee Count 12 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -129.57K Effective Tax Rate 0.97%
Stock Price Statistics The stock price has increased by 3.75% in the
last 52 weeks. The beta is 0, so Blue Water Vaccines's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change 3.75% 50-Day Moving Average 0.26 200-Day Moving Average 0.72 Relative Strength Index (RSI) 32.4 Average Volume (20 Days) 435,531
Income Statement
Revenue n/a Gross Profit n/a Operating Income -13.48M Net Income -13.29M EBITDA -13.48M EBIT n/a Earnings Per Share (EPS) -1.08
Full Income Statement Balance Sheet The company has 25.75M in cash and 0 in
debt, giving a net cash position of 25.75M.
Cash & Cash Equivalents 25.75M Total Debt n/a Net Cash n/a Retained Earnings -19.38M Total Assets 27.88M Working Capital -8.1M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.7M
and capital expenditures -9.34K, giving a free cash flow of -8.71M.
Operating Cash Flow -8.7M Capital Expenditures -9.34K Free Cash Flow -8.71M FCF Per Share -0.71
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
